Patients with type 2 diabetes and atopic dermatitis show higher risk for cardiovascular events, but GLP-1 agonists reduce the ...

A large trial in a primary care setting found daily emollient use to be safe, feasible, and effective in reducing atopic ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3b/4 clinical study ...

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease that significantly impacts quality of life and often ...

Total yearly flares in atopic dermatitis correlate with disease severity and impaired quality of life, influencing treatment decisions. Higher flare frequency is associated with increased disease ...

"The study adds to growing evidence that dupilumab, while highly effective for managing atopic dermatitis, may also be linked ...

Nektar Therapeutics is fairly valued based on rNPV modeling, but multiple near-term catalysts could drive upside. Learn why ...

With sales of atopic dermatitis (AD) treatment Adbry scaling up in the U.S., Leo Pharma is accomplishing one of the goals established by CEO Christophe Bourdon when he took over at the Danish ...

Discover a study showing how online clustered nursing care improves symptoms and enhances sleep quality in adults with atopic dermatitis.

The Phase II EvolvE trial (NCT05774184) confirmed barzolvolimab’s mechanism of action but showed no measurable improvement in dysphagia symptoms or esophageal inflammation in patients with ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.